{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T22:39:03Z","timestamp":1787524743912,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["RIA2018CO-2512"],"award-info":[{"award-number":["RIA2018CO-2512"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Glob. Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Electronic monitoring devices (EMDs) may provide an objective method for assessing medication adherence. However, evidence on their validity compared to other adherence measures, their functional feasibility, and their acceptability, especially among adolescents, remains limited. Adolescents face multifaceted adherence challenges, yet there is a lack of evidence to inform the use of digital tools for adherence monitoring and support in this age group, particularly in low-income settings. We assessed feasibility, acceptability, and validity of an EMD among adolescents enrolled in the multi-country clinical trial VITALITY.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An explanatory sequential mixed methods study was embedded within the Zimbabwean site of the VITALITY trial, a randomised controlled trial evaluating weekly vitamin D supplementation on bone health in adolescents living with HIV. A random sample of 97 participants (aged 11\u201319\u00a0years) was provided an EMD for 24\u00a0weeks to monitor adherence to vitamin D or placebo. Validity was assessed by correlating EMD-measured adherence with serum vitamin D levels. Feasibility of the EMD was investigated through records of battery duration, network connectivity, and EMD malfunction. Seventeen participants were purposively selected for qualitative exit interviews to explore acceptability and reasons for discordance between adherence measured through the EMD and pill count.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Ninety-seven participants, median age 16.7 (interquartile range13.5, 18.7) years, 50 (51.5%) female were provided with the EMD for a median of 24 (range 22\u201325) weeks. There was a strong positive correlation between EMD-measured adherence and week-48 vitamin D levels (\u03b2\u2009=\u20090.63, 95% CI: 0.42\u20130.85; R\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.42;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), supporting the validity of EMD data as a proxy for medication intake. The EMD functioned reliably despite intermittent network coverage, and no major malfunctions were reported. Adolescents found the EMDs highly acceptable due to their ease of use, discretion, and perceived motivational benefits.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates that EMDs are valid, feasible, and acceptable tools for monitoring adherence among adolescents in low-income settings. These findings support the potential for broader use of EMDs to promote and monitor adherence to long-term treatments in adolescents beyond research settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Pan African Clinical Trials Registry (PACTR),\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/pactr.samrc.ac.za\/TrialDisplay.aspx?TrialID=12318\" ext-link-type=\"uri\">PACTR202009897660297<\/jats:ext-link>\n                      .\u00a0\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s44263-026-00248-z","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:25:05Z","timestamp":1770726305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Feasibility, acceptability and validity of electronic adherence monitoring among adolescents in Zimbabwe: a mixed methods study"],"prefix":"10.1186","volume":"4","author":[{"given":"Nyasha V.","family":"Dzavakwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance RS.","family":"Mackworth-Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palwasha Y.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilda A.","family":"Mujuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazvita","family":"Paradza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall T.","family":"Chiwodza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panashe","family":"Bluck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol","family":"Redzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsitsi","family":"Bandason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Kranzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashida A.","family":"Ferrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Simms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"issue":"1","key":"248_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/pch\/13.1.19","volume":"13","author":"D Taddeo","year":"2008","unstructured":"Taddeo D, Egedy M, Frappier J-Y. Adherence to treatment in adolescents. Paediatr Child Health. 2008;13(1):19\u201324.","journal-title":"Paediatr Child Health"},{"issue":"9","key":"248_CR2","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/00005650-200209000-00009","volume":"40","author":"MR DiMatteo","year":"2002","unstructured":"DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794\u2013811.","journal-title":"Med Care"},{"issue":"6","key":"248_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S1054-139X(99)00042-7","volume":"26","author":"HA Kyng\u00e4s","year":"2000","unstructured":"Kyng\u00e4s HA, Kroll T, Duffy ME. Compliance in adolescents with chronic diseases: a review. J Adolesc Health. 2000;26(6):379\u201388.","journal-title":"J Adolesc Health"},{"issue":"1","key":"248_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/02739615.2011.537934","volume":"40","author":"ALH Pai","year":"2011","unstructured":"Pai ALH, Ostendorf HM. Treatment adherence in adolescents and young adults affected by chronic illness during the health care transition from pediatric to adult health care: a literature review. Child Health Care. 2011;40(1):16\u201333.","journal-title":"Child Health Care"},{"key":"248_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/217047","volume":"2015","author":"WY Lam","year":"2015","unstructured":"Lam WY, Fresco P. Medication adherence measures: an overview. BioMed Res Int. 2015;2015:217047.","journal-title":"BioMed Res Int"},{"key":"248_CR6","doi-asserted-by":"crossref","unstructured":"Chua B, Morgan J, Yap KZ. Refill Adherence Measures and Its Association with Economic, Clinical, and Humanistic Outcomes Among Pediatric Patients: A Systematic Review.\u00a0Int J Environ Res Public Health. 2020;17(6):2133. https:\/\/doi.org\/10.3390\/ijerph17062133.","DOI":"10.3390\/ijerph17062133"},{"issue":"1","key":"248_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-1035","volume":"14","author":"RZ Sangeda","year":"2014","unstructured":"Sangeda RZ, Mosha F, Prosperi M, Aboud S, Vercauteren J, Camacho RJ, et al. Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings. BMC Public Health. 2014;14(1):1035.","journal-title":"BMC Public Health"},{"key":"248_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac483","author":"N Gawler","year":"2022","unstructured":"Gawler N, Reynolds SJ, Hsiao N-Y, Clarke W, Maartens G, Abrams EJ, et al. Routine antiretroviral pharmacy refill information can predict failure postpartum in previously suppressed South African women with HIV. Open Forum Infect Dis. 2022. https:\/\/doi.org\/10.1093\/ofid\/ofac483.","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"248_CR9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1089\/aid.2015.0111","volume":"31","author":"W Prasitsuebsai","year":"2015","unstructured":"Prasitsuebsai W, Kerr SJ, Truong KH, Ananworanich J, Do VC, Nguyen LV, et al. Using lopinavir concentrations in hair samples to assess treatment outcomes on second-line regimens among Asian children. AIDS Res Hum Retroviruses. 2015;31(10):1009\u201314.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"6","key":"248_CR10","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1586\/14737175.8.6.929","volume":"8","author":"SI Johannessen","year":"2008","unstructured":"Johannessen SI, Landmark CJ. Value of therapeutic drug monitoring in epilepsy. Expert Rev Neurother. 2008;8(6):929\u201339.","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"248_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5001\/omj.2011.38","volume":"26","author":"B Jimmy","year":"2011","unstructured":"Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155\u20139.","journal-title":"Oman Med J"},{"key":"248_CR12","doi-asserted-by":"publisher","DOI":"10.1023\/A:1014131928789","author":"KA Riekert","year":"2002","unstructured":"Riekert KA, Rand C. Electronic monitoring of medication adherence: when is high-tech best? J Clin Psychol Med Settings. 2002. https:\/\/doi.org\/10.1023\/A:1014131928789.","journal-title":"J Clin Psychol Med Settings"},{"key":"248_CR13","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","volume":"21","author":"KC Farmer","year":"1999","unstructured":"Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21:1074\u201390.","journal-title":"Clin Ther"},{"issue":"9","key":"248_CR14","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1007\/s11606-020-05905-z","volume":"35","author":"ME McGrady","year":"2020","unstructured":"McGrady ME, Ramsey RR. Using electronic monitoring devices to assess medication adherence: a research methods framework. J Gen Intern Med. 2020;35(9):2707\u201314.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"248_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11904-018-0413-0","volume":"15","author":"KM Bell","year":"2018","unstructured":"Bell KM, Haberer JE. Actionable adherence monitoring: technological methods to monitor and support adherence to antiretroviral therapy. Curr HIV AIDS Rep. 2018;15(5):388\u201396.","journal-title":"Curr HIV AIDS Rep"},{"issue":"5","key":"248_CR16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1586\/17512433.2014.940896","volume":"7","author":"B Vrijens","year":"2014","unstructured":"Vrijens B, Urquhart J, White D. Electronically monitored dosing histories can be used to develop a medication-taking habit and manage patient adherence. Expert Rev Clin Pharmacol. 2014;7(5):633\u201344.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"5","key":"248_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036737","volume":"7","author":"JE Haberer","year":"2012","unstructured":"Haberer JE, Kiwanuka J, Nansera D, Ragland K, Mellins C, Bangsberg DR. Multiple measures reveal antiretroviral adherence successes and challenges in HIV-infected Ugandan children. PLoS ONE. 2012;7(5):e36737.","journal-title":"PLoS ONE"},{"key":"248_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2024.104903","author":"NV Dzavakwa","year":"2024","unstructured":"Dzavakwa NV, Kranzer K, Khan P, Mackworth-Young CRS, Mujuru HA, Ferrand RA, et al. Electronic monitoring device informed interventions for treatment adherence and clinical outcomes in children and adolescents: a systematic review. Int J Nurs Stud. 2024. https:\/\/doi.org\/10.1016\/j.ijnurstu.2024.104903.","journal-title":"Int J Nurs Stud"},{"issue":"10","key":"248_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185453","volume":"12","author":"M Van Heuckelum","year":"2017","unstructured":"Van Heuckelum M, Van Den Ende CHM, Houterman AEJ, Heemskerk CPM, Van Dulmen S, Van Den Bemt BJF. The effect of electronic monitoring feedback on medication adherence and clinical outcomes: a systematic review. PLoS ONE. 2017;12(10):e0185453.","journal-title":"PLoS ONE"},{"key":"248_CR20","unstructured":"Creswell JW, Plano Clark VL. Designing and Conducting Mixed Methods Research (3rd ed.). Thousand Oaks, CA: SAGE; 2018."},{"issue":"1","key":"248_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/s13063-024-08342-z","volume":"25","author":"NV Dzavakwa","year":"2024","unstructured":"Dzavakwa NV, Chisenga M, McHugh G, Filteau S, Gregson CL, Kasonka L, et al. Update: vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial. Trials. 2024;25(1):499.","journal-title":"Trials"},{"issue":"2","key":"248_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S2352-4642(25)00301-3","volume":"10","author":"RA Ferrand","year":"2026","unstructured":"Ferrand RA, Dzavakwa NV, Bandason T, Chisenga M, Filteau S, Kranzer K, et al. Impact of high-dose vitamin D and calcium carbonate supplementation on bone density in adolescents living with HIV: a randomised, placebo-controlled trial. The Lancet Child & Adolescent Health. 2026;10(2):111\u201321.","journal-title":"The Lancet Child & Adolescent Health"},{"key":"248_CR23","unstructured":"Zambia Demographics 2025 (Population, Age, Sex, Trends) - Worldometer 2025. Available from: https:\/\/www.worldometers.info\/demographics\/zambia-demographics\/#urb. 2025 Nov 18."},{"key":"248_CR24","unstructured":"City Of Harare | About Harare 2025. Available from: https:\/\/www.hararecity.co.zw\/about. 2025 Nov 18."},{"issue":"2","key":"248_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3946\/kjme.2017.53","volume":"29","author":"JA Cleland","year":"2017","unstructured":"Cleland JA. The qualitative orientation in medical education research. Korean Journal of Medical Education. 2017;29(2):61\u201371.","journal-title":"Korean Journal of Medical Education"},{"key":"248_CR26","unstructured":"Wisepill Technologies. Wisepill Technologies. Available from: https:\/\/www.wisepill.com\/.\u00a0"},{"key":"248_CR27","doi-asserted-by":"publisher","unstructured":"Madanhire T, Ward KA, MacDougall A, Mohammed NI, Kasonka L, Mabuda HB, Chisenga M, Tang JCY, Fraser WD, Bandason T, Dzavakwa NV, Simms V, Ferrand RA, Gregson CL. The association between 25-hydroxyvitamin D and parathyroid hormone in adolescents living with HIV in southern Africa: a cross-sectional study.\u00a0Br J Nutr. 2025;133(7):1\u20137. Advance online publication. https:\/\/doi.org\/10.1017\/S0007114525000509.","DOI":"10.1017\/S0007114525000509"},{"key":"248_CR28","unstructured":"Wisniewski SJ, Brannan GD. Correlation (Coefficient, Partial, and Spearman Rank) and Regression Analysis - StatPearls - NCBI Bookshelf 2024. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK606101\/. 2025 Nov 18."},{"issue":"5","key":"248_CR29","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","volume":"126","author":"P Schober","year":"2018","unstructured":"Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126(5):1763\u20138.","journal-title":"Anesth Analg"},{"key":"248_CR30","doi-asserted-by":"publisher","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.\u00a0Int J Qual Health Care. 2007;19(6):349\u201357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042.","DOI":"10.1093\/intqhc\/mzm042"},{"issue":"5","key":"248_CR31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/00007691-200210000-00001","volume":"24","author":"PW Hugen","year":"2002","unstructured":"Hugen PW, Burger DM, Aarnoutse RE, Baede PA, Nieuwkerk PT, Koopmans PP, et al. Therapeutic drug monitoring of HIV-protease inhibitors to assess noncompliance. Ther Drug Monit. 2002;24(5):579\u201387.","journal-title":"Ther Drug Monit"},{"issue":"3","key":"248_CR32","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.3390\/s100301652","volume":"10","author":"L De Bleser","year":"2010","unstructured":"De Bleser L, De Geest S, Vandenbroeck S, Vanhaecke J, Dobbels F. How accurate are electronic monitoring devices? A laboratory study testing two devices to measure medication adherence. Sensors. 2010;10(3):1652\u201360.","journal-title":"Sensors"},{"issue":"3","key":"248_CR33","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s10461-017-1724-7","volume":"22","author":"V Mudhune","year":"2018","unstructured":"Mudhune V, Gvetadze R, Girde S, Ndivo R, Angira F, Zeh C, et al. Correlation of adherence by pill count, self-report, MEMS and plasma drug levels to treatment response among women receiving ARV therapy for PMTCT in Kenya. AIDS Behav. 2018;22(3):918\u201328.","journal-title":"AIDS Behav"},{"issue":"4","key":"248_CR34","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10461-009-9555-9","volume":"14","author":"CJ Gill","year":"2010","unstructured":"Gill CJ, Sabin LL, Hamer DH, Keyi X, Jianbo Z, Li T, et al. Importance of dose timing to achieving undetectable viral loads. AIDS Behav. 2010;14(4):785\u201393.","journal-title":"AIDS Behav"},{"issue":"5","key":"248_CR35","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1177\/0193945911427153","volume":"34","author":"P Cook","year":"2012","unstructured":"Cook P, Schmiege S, McClean M, Aagaard L, Kahook M. Practical and analytic issues in the electronic assessment of adherence. West J Nurs Res. 2012;34(5):598\u2013620.","journal-title":"West J Nurs Res"},{"key":"248_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01540","author":"M Burnier","year":"2019","unstructured":"Burnier M. Is there a threshold for medication adherence? Lessons learnt from electronic monitoring of drug adherence. Front Pharmacol. 2019. https:\/\/doi.org\/10.3389\/fphar.2018.01540.","journal-title":"Front Pharmacol"},{"key":"248_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/PPA.S238759","volume":"14","author":"C Muiruri","year":"2020","unstructured":"Muiruri C, Jazowski SA, Semvua SK, Karia FP, Knettel BA, Zullig LL, et al. Does Antiretroviral Therapy Packaging Matter? Perceptions and Preferences of Antiretroviral Therapy Packaging for People Living with HIV in Northern Tanzania. Patient Prefer Adherence. 2020;14:153\u201361.","journal-title":"Patient Prefer Adherence"},{"issue":"10","key":"248_CR38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s40267-017-0431-9","volume":"33","author":"V Albert","year":"2017","unstructured":"Albert V, Lanz M, Imanidis G, Hersberger KE, Arnet I. Stability of medicines after repackaging into multicompartment compliance aids: eight criteria for detection of visual alteration. Drugs Ther Perspect. 2017;33(10):487\u201396.","journal-title":"Drugs Ther Perspect"},{"key":"248_CR39","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10461-011-9933-y","volume":"16","author":"JE Haberer","year":"2012","unstructured":"Haberer JE, Robbins GK, Ybarra M, Monk A, Ragland K, Weiser SD, et al. Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behav. 2012;16:375\u201382.","journal-title":"AIDS Behav"},{"issue":"5","key":"248_CR40","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.9031","volume":"6","author":"A Musiimenta","year":"2018","unstructured":"Musiimenta A, Atukunda EC, Tumuhimbise W, Pisarski EE, Tam M, Wyatt MA, et al. Acceptability and feasibility of real-time antiretroviral therapy adherence interventions in rural Uganda: mixed-method pilot randomized controlled trial. JMIR Mhealth Uhealth. 2018;6(5):e122.","journal-title":"JMIR Mhealth Uhealth"},{"key":"248_CR41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1471-2458-11-92","volume":"11","author":"RA Lyimo","year":"2011","unstructured":"Lyimo RA, Boogaard JVD, Msoka E, Hospers HJ, Ven A, Mushi D, et al. Measuring adherence to antiretroviral therapy in northern Tanzania: Feasibility and acceptability of the Medication Event Monitoring System. BMC Public Health. 2011;11:92.","journal-title":"BMC Public Health"},{"issue":"2","key":"248_CR42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S1054-139X(04)00086-2","volume":"35","author":"C Ford","year":"2004","unstructured":"Ford C, English A, Sigman G. Confidential health care for adolescents: position paper of the Society for Adolescent Medicine. J Adolesc Health. 2004;35(2):160\u20137.","journal-title":"J Adolesc Health"},{"key":"248_CR43","doi-asserted-by":"publisher","unstructured":"Bachman DeSilva M, Gifford A. Real-time electronic drug monitoring for HIV-positive adolescents: promising acceptability and feasibility in China. J AIDS Clin Res. 2016;7:586. https:\/\/doi.org\/10.4172\/2155-6113.1000586.","DOI":"10.4172\/2155-6113.1000586"},{"key":"248_CR44","doi-asserted-by":"crossref","unstructured":"Sabin LL, DeSilva MB, Hamer DH, Xu K, Zhang J, Li T, et al. Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in China. AIDS and Behavior. 2010;14:580\u20139. pmid = 19771504 , publisher = AIDS Behav.","DOI":"10.1007\/s10461-009-9615-1"},{"key":"248_CR45","unstructured":"ITU. Measuring digital development: Facts and Figures. 2022. Cited 2023 1 December."},{"issue":"1","key":"248_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-5-137","volume":"5","author":"JM Kirigia","year":"2005","unstructured":"Kirigia JM, Seddoh A, Gatwiri D, Muthuri LH, Seddoh J. E-health: determinants, opportunities, challenges and the way forward for countries in the WHO African Region. BMC Public Health. 2005;5(1):1\u201311.","journal-title":"BMC Public Health"},{"key":"248_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.glmedi.2024.100077","volume":"2","author":"BM Ukoaka","year":"2024","unstructured":"Ukoaka BM, Ugwuanyi EA, Ukueku KO, Ajah KU, Udam NG, Daniel FM, et al. Digital tools for improving antiretroviral adherence among people living with HIV in Africa. J Med Surg Public Health. 2024;2:100077.","journal-title":"J Med Surg Public Health"},{"key":"248_CR48","doi-asserted-by":"publisher","DOI":"10.1097\/MD9.0000000000000363","author":"NV Dzavakwa","year":"2025","unstructured":"Dzavakwa NV, Paradza M, Kembo D, Chidembo M, Munemo D, Makamba M, et al. Young people, ART, and adherence. Medicine: Case Reports and Study Protocols. 2025. https:\/\/doi.org\/10.1097\/MD9.0000000000000363.","journal-title":"Medicine: Case Reports and Study Protocols"},{"issue":"1","key":"248_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/diseases1010018","volume":"1","author":"AO Adefolalu","year":"2013","unstructured":"Adefolalu AO, Nkosi ZZ. The complex nature of adherence in the management of HIV\/AIDS as a chronic medical condition. Diseases. 2013;1(1):18\u201335.","journal-title":"Diseases"},{"issue":"4","key":"248_CR50","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4065\/mcp.2010.0575","volume":"86","author":"MT Brown","year":"2011","unstructured":"Brown MT, Bussell JK. Medication adherence: who cares? Mayo Clin Proc. 2011;86(4):304\u201314.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"248_CR51","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/ejcn.2015.16","volume":"69","author":"B Oliveri","year":"2015","unstructured":"Oliveri B, Mastaglia SR, Brito GM, Seijo M, Keller GA, Somoza J, et al. Vitamin D3 seems more appropriate than D2 to sustain adequate levels of 25OHD: a pharmacokinetic approach. Eur J Clin Nutr. 2015;69(6):697\u2013702.","journal-title":"Eur J Clin Nutr"},{"issue":"10","key":"248_CR52","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1210\/jc.2017-01187","volume":"102","author":"I Martinaityte","year":"2017","unstructured":"Martinaityte I, Kamycheva E, Didriksen A, Jakobsen J, Jorde R. Vitamin d stored in fat tissue during a 5-year intervention affects serum 25-hydroxyvitamin d levels the following year. J Clin Endocrinol Metab. 2017;102(10):3731\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"248_CR53","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3945\/an.117.015578","volume":"8","author":"KD Cashman","year":"2017","unstructured":"Cashman KD, van den Heuvel EGHM, Schoemaker RJW, Pr\u00e9v\u00e9raud DP, Macdonald HM, Arcot J. 25-hydroxyvitamin D as a biomarker of vitamin D status and its modeling to inform strategies for prevention of vitamin D deficiency within the population. Adv Nutr. 2017;8(6):947\u201357.","journal-title":"Adv Nutr"}],"container-title":["BMC Global and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44263-026-00248-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44263-026-00248-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44263-026-00248-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:09:34Z","timestamp":1770772174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s44263-026-00248-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["248"],"URL":"https:\/\/doi.org\/10.1186\/s44263-026-00248-z","relation":{},"ISSN":["2731-913X"],"issn-type":[{"value":"2731-913X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants under 18\u00a0years of age gave written informed assent alongside guardian written consent. Those aged 18\u00a0years and older or emancipated minors (those aged below 16\u00a0years of age who were married, pregnant or had children) gave independent consent to participate in this study. The consent procedure was separate from consent procedures to participate in the parent trial. Ethical approval was obtained from the Medical Research Council of Zimbabwe (Reference number: A\/2626) and the London School of Hygiene and Tropical Medicine Ethics Committee (Reference number: 22030). All study procedures were conducted in accordance with the ethical principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}